Development of virus-specific CD4+ and CD8+ regulatory T cells induced by human herpesvirus 6 infection

Journal of Virology

Volumn 88, Issue 2, 2014, Pages 1011-1024

  Wang, Fang ^a   Chi, Jing ^b,c   Peng, Guangyong ^d   Zhou, Feng ^b   Wang, Jinfeng ^b   Li, Lingyun ^b   Feng, Dongju ^b   Xie, Fangyi ^b   Gu, Bin ^b   Qin, Jian ^e   Chen, Yun ^b   Yao, Kun ^b  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HOHAI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CONTACT; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 6; IMMUNE RESPONSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; VIRUS IMMUNITY;

CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DENDRITIC CELLS; HERPESVIRUS 6, HUMAN; HUMANS; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; ROSEOLOVIRUS INFECTIONS; T-LYMPHOCYTES, REGULATORY;

EID: 84891707519     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02586-13     Document Type: Article

References (52)

1. Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan M, Halligan G, Biberfeld P, Wong-Staal F, Kramarsky B, et al. 1986. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234:596-601. http://dx.doi.org/10.1126/science.2876520.
2. Soldan SS, Berti R, Salem N, Secchiero P, Flamand L, Calabresi PA, Brennan MB, Maloni HW, McFarland HF, Lin HC, Patnaik M, Jacobson S. 1997. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat. Med. 3:1394-1397. http://dx.doi.org/10.1038/nm1297-1394.
3. Ogata M. 2009. Human herpesvirus 6 in hematological malignancies. J. Clin. Exp. Hematop. 49:57-67. http://dx.doi.org/10.3960/jslrt.49.57.
4. Lautenschlager I, Razonable RR. 2012. Human herpesvirus-6 infections in kidney, liver, lung, and heart transplantation: review. Transpl. Int. 25:493-502. http://dx.doi.org/10.1111/j.1432-2277.2012.01443.x.
5. Crawford JR, Santi MR, Cornelison R, Sallinen SL, Haapasalo H, MacDonald TJ. 2009. Detection of human herpesvirus-6 in adult central nervous system tumors: predominance of early and late viral antigens in glial tumors. J. Neurooncol. 95:49-60. http://dx.doi.org/10.1007/s11060-009-9908-2.
6. Neves AM, Thompson G, Carvalheira J, Trindade JC, Rueff J, Caetano JM, Casey JW, Hermouet S. 2008. Detection and quantitative analysis of human herpesvirus in pilocytic astrocytoma. Brain Res. 1221:108-114. http://dx.doi.org/10.1016/j.brainres.2008.05.009.
7. Saddawi-Konefka R, Crawford JR. 2010. Chronic viral infection and primary central nervous system malignancy. J. Neuroimmune Pharmacol. 5:387-403. http://dx.doi.org/10.1007/s11481-010-9204-0.
8. Chi J, Gu B, Zhang C, Peng G, Zhou F, Chen Y, Zhang G, Guo Y, Guo D, Qin J, Wang J, Li L, Wang F, Liu G, Xie F, Feng D, Zhou H, Huang X, Lu S, Liu Y, Hu W, Yao K. 2012. Human herpesvirus 6 latent infection in patients with glioma. J. Infect. Dis. 206:1394-1398. http://dx.doi.org/10.1093/infdis/jis513.
9. Lusso P. 2006. HHV-6 and the immune system: mechanisms of immunomodulation and viral escape. J. Clin. Virol. 37(Suppl 1):S4-S10. http://dx.doi.org/10.1016/S1386-6532(06)70004-X.
10. Niiya H, Lei J, Guo Y, Azuma T, Yakushijin Y, Sakai I, Hato T, Tohyama M, Hashimoto K, Yasukawa M. 2006. Human herpesvirus 6 impairs differentiation of monocytes to dendritic cells. Exp. Hematol. 34:642-653. http://dx.doi.org/10.1016/j.exphem.2006.02.001.
11. 2/M phase. J. Virol. 85:6774-6783. http://dx.doi.org/10.1128/JVI.02577-10.
12. Li S, Jones KL, Woollard DJ, Dromey J, Paukovics G, Plebanski M, Gowans EJ. 2007. Defining target antigens for CD25+ FOXP3+ IFN-gamma-regulatory T cells in chronic hepatitis C virus infection. Immunol. Cell Biol. 85:197-204. http://dx.doi.org/10.1038/sj.icb.7100020.
13. Sempere JM, Soriano V, Benito JM. 2007. T regulatory cells and HIV infection. AIDS Rev. 9:54-60.
14. Voo KS, Peng G, Guo Z, Fu T, Li Y, Frappier L, Wang RF. 2005. Functional characterization of EBV-encoded nuclear antigen 1-specific CD4+ helper and regulatory T cells elicited by in vitro peptide stimulation. Cancer Res. 65:1577-1586. http://dx.doi.org/10.1158/0008-5472.CAN-04-2552.
15. Wang F, Yao K, Yin QZ, Zhou F, Ding CL, Peng GY, Xu J, Chen Y, Feng DJ, Ma CL, Xu WR. 2006. Human herpesvirus-6-specific interleukin 10-producing CD4+ T cells suppress the CD4+ T-cell response in infected individuals. Microbiol. Immunol. 50:787-803. http://dx.doi.org/10.1111/j.1348-0421.2006.tb03855.x.
16. Chi J, Wang F, Li L, Feng D, Qin J, Xie F, Zhou F, Chen Y, Wang J, Yao K. 2012. The role of MAPK in CD4(+) T cells toll-like receptor 9-mediated signaling following HHV-6 infection. Virology 422:92-98. http://dx.doi.org/10.1016/j.virol.2011.09.026.
17. Yakushijin Y, Yasukawa M, Kobayashi Y. 1992. Establishment and functional characterization of human herpesvirus 6-specific CD4+ human T-cell clones. J. Virol. 66:2773-2779.
18. Yasukawa M, Yakushijin Y, Furukawa M, Fujita S. 1993. Specificity analysis of human CD4+ T-cell clones directed against human herpesvirus 6 (HHV-6), HHV-7, and human cytomegalovirus. J. Virol. 67:6259-6264.
19. Wang HY, Lee DA, Peng G, Guo Z, Li Y, Kiniwa Y, Shevach EM, Wang RF. 2004. Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy. Immunity 20:107-118. http://dx.doi.org/10.1016/S1074-7613(03)00359-5.
20. Peng G, Wang HY, Peng W, Kiniwa Y, Seo KH, Wang RF. 2007. Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway. Immunity 27:334-348. http://dx.doi.org/10.1016/j.immuni.2007.05.020.
21. Oderup C, Cederbom L, Makowska A, Cilio CM, Ivars F. 2006. Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression. Immunology 118:240-249. http://dx.doi.org/10.1111/j.1365-2567.2006.02362.x.
22. Sarangi PP, Sehrawat S, Suvas S, Rouse BT. 2008. IL-10 and natural regulatory T cells: two independent anti-inflammatory mechanisms in herpes simplex virus-induced ocular immunopathology. J. Immunol. 180:6297-6306. http://www.jimmunol.org/content/180/9/6297.
23. Pyzik M, Piccirillo CA. 2007. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets. J. Leukoc. Biol. 82:335-346. http://dx.doi.org/10.1189/jlb.1006644.
24. Curotto de Lafaille MA, Lafaille JJ. 2009. Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? Immunity 30:626-635. http://dx.doi.org/10.1016/j.immuni.2009.05.002.
25. Pot C, Apetoh L, Kuchroo VK. 2011. Type 1 regulatory T cells (Tr1) in autoimmunity. Semin. Immunol. 23:202-208. http://dx.doi.org/10.1016/j.smim.2011.07.005.
26. Kiniwa Y, Miyahara Y, Wang HY, Peng W, Peng G, Wheeler TM, Thompson TC, Old LJ, Wang RF. 2007. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer. Clin. Cancer Res. 13:6947-6958. http://dx.doi.org/10.1158/1078-0432.CCR-07-0842.
27. Billerbeck E, Thimme R. 2008. CD8+ regulatory T cells in persistent human viral infections. Hum. Immunol. 69:771-775. http://dx.doi.org/10.1016/j.humimm.2008.07.016.
28. Vahlenkamp TW, Tompkins MB, Tompkins WA. 2005. The role of CD4+CD25+ regulatory T cells in viral infections. Vet. Immunol. Immunopathol. 108:219-225. http://dx.doi.org/10.1016/j.vetimm.2005.07.011.
29. Petitjean G, Chevalier MF, Tibaoui F, Didier C, Manea ME, Liovat AS, Campa P, Muller-Trutwin M, Girard PM, Meyer L, Barre-Sinoussi F, Scott-Algara D, Weiss L. 2012. Level of double negative T cells, which produce TGF-beta and IL-10, predicts CD8 T-cell activation in primary HIV-1 infection. AIDS 26:139-148. http://dx.doi.org/10.1097/QAD.0b013e32834e1484.
30. Ebinuma H, Nakamoto N, Li Y, Price DA, Gostick E, Levine BL, Tobias J, Kwok WW, Chang KM. 2008. Identification and in vitro expansion of functional antigen-specific CD25+FoxP3+ regulatory T cells in hepatitis C virus infection. J. Virol. 82:5043-5053. http://dx.doi.org/10.1128/JVI.01548-07.
31. Oh JS, Kim YG, Lee SG, So MW, Choi SW, Lee CK, Yoo B. 2013. The effect of various disease-modifying anti-rheumatic drugs on the suppressive function of CD4(+)CD25 (+) regulatory T cells. Rheumatol Int. 33:381-388. http://dx.doi.org/10.1007/s00296-012-2365-9.
32. Nastke MD, Becerra A, Yin L, Dominguez-Amorocho O, Gibson L, Stern LJ, Calvo-Calle JM. 2012. Human CD4+ T cell response to human herpesvirus 6. J. Virol. 86:4776-4792. http://dx.doi.org/10.1128/JVI.06573-11.
33. Wang H, Daniel V, Sadeghi M, Opelz G. 2013. Plasticity and overlap of in vitro-induced regulatory T-cell markers in healthy humans. Transplant. Proc. 45:1816-1821. http://dx.doi.org/10.1016/j.transproceed.2012.10.060.
34. Daniel V, Naujokat C, Sadeghi M, Weimer R, Renner F, Yildiz S, Opelz G. 2008. Observational support for an immunoregulatory role of CD3+CD4+CD25+IFN-gamma+ blood lymphocytes in kidney transplant recipients with good long-term graft outcome. Transpl. Int. 21:646-660. http://dx.doi.org/10.1111/j.1432-2277.2008.00662.x.
35. Stroopinsky D, Avivi I, Rowe JM, Avigan D, Katz T. 2009. Allogeneic induced human FOXP3(+)IFN-gamma(+) T cells exhibit selective suppressive capacity. Eur. J. Immunol. 39:2703-2715. http://dx.doi.org/10.1002/eji.200839097.
36. Takemoto M, Imasawa T, Yamanishi K, Mori Y. 2009. Role of dendritic cells infected with human herpesvirus 6 in virus transmission to CD4(+) T cells. Virology 385:294-302. http://dx.doi.org/10.1016/j.virol.2008.11.049.
37. Janelle ME, Flamand L. 2006. Phenotypic alterations and survival of monocytes following infection by human herpesvirus-6. Arch. Virol. 151:1603-1614. http://dx.doi.org/10.1007/s00705-005-0715-6.
38. Nace G, Evankovich J, Eid R, Tsung A. 2012. Dendritic cells and damage-associated molecular patterns: endogenous danger signals linking innate and adaptive immunity. J. Innate immun. 4:6-15. http://dx.doi.org/10.1159/000334245.
39. de la Rosa M, Rutz S, Dorninger H, Scheffold A. 2004. Interleukin-2 is essential for CD4+CD25+ regulatory T cell function. Eur. J. Immunol. 34:2480-2488. http://dx.doi.org/10.1002/eji.200425274.
40. Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM, Cross R, Sehy D, Blumberg RS, Vignali DA. 2007. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450:566-569. http://dx.doi.org/10.1038/nature06306.
41. Peng G, Guo Z, Kiniwa Y, Voo KS, Peng W, Fu T, Wang DY, Li Y, Wang HY, Wang RF. 2005. Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function. Science 309:1380-1384. http://dx.doi.org/10.1126/science.1113401.
42. Gondek DC, Lu LF, Quezada SA, Sakaguchi S, Noelle RJ. 2005. Contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J. Immunol. 174:1783-1786. http://www.jimmunol.org/content/174/4/1783.
43. Sakaguchi S, Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T. 2009. Regulatory T cells: how do they suppress immune responses? Int. Immunol. 21:1105-1111. http://dx.doi.org/10.1093/intimm/dxp095.
44. Field EH, Kulhankova K, Nasr ME. 2007. Natural Tregs, CD4+CD25+ inhibitory hybridomas, and their cell contact dependent suppression. Immunol. Res. 39:62-78. http://dx.doi.org/10.1007/s12026-007-0064-5.
45. Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, Chen JF, Enjyoji K, Linden J, Oukka M, Kuchroo VK, Strom TB, Robson SC. 2007. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204:1257-1265. http://dx.doi.org/10.1084/jem.20062512.
46. Erdman SE, Poutahidis T. 2010. Roles for inflammation and regulatory T cells in colon cancer. Toxicol. Pathol. 38:76-87. http://dx.doi.org/10.1177/0192623309354110.
47. Wingate PJ, McAulay KA, Anthony IC, Crawford DH. 2009. Regulatory T cell activity in primary and persistent Epstein-Barr virus infection. J. Med. Virol. 81:870-877. http://dx.doi.org/10.1002/jmv.21445.
48. Periasamy S, Dhiman R, Barnes PF, Paidipally P, Tvinnereim A, Bandaru A, Valluri VL, Vankayalapati R. 2011. Programmed death 1 and cytokine inducible SH2-containing protein dependent expansion of regulatory T cells upon stimulation with Mycobacterium tuberculosis. J. Infect. Dis. 203:1256-1263. http://dx.doi.org/10.1093/infdis/jir011.
49. Garg A, Barnes PF, Roy S, Quiroga MF, Wu S, Garcia VE, Krutzik SR, Weis SE, Vankayalapati R. 2008. Mannose-capped lipoarabinomannanand prostaglandin E2-dependent expansion of regulatory T cells in human Mycobacterium tuberculosis infection. Eur. J. Immunol. 38:459-469. http://dx.doi.org/10.1002/eji.200737268.
50. Trinath J, Maddur MS, Kaveri SV, Balaji KN, Bayry J. 2012. Mycobacterium tuberculosis promotes regulatory T-cell expansion via induction of programmed death-1 ligand 1 (PD-L1, CD274) on dendritic cells. J. Infect. Dis. 205:694-696. http://dx.doi.org/10.1093/infdis/jir820.
51. Gerdemann UKL, Keirnan JM, Katari UL, Nguyen CT, de Pagter AP, Ramos CA, Kennedy-Nasser A, Gottschalk SM, Heslop HE, Brenner MK, Rooney CM, Leen AM. 2013. Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantation. Blood 121:207-218. http://dx.doi.org/10.1182/blood-2012-05-430413.
52. Martin LK SA, Dillinger S, Moosmann A. 2012. Specific CD8+ T cells recognize human herpesvirus 6B. Eur. J. Immunol. 42:2901-2912. http://dx.doi.org/10.1002/eji.201242439.